News from enteris biopharma, inc

Jun 20, 2014, 08:10 ET

Enteris BioPharma Oral Peptide Delivery Technology Enables Key Clinical Milestone for Acute and Chronic Pain Drug

 Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced that its development partner, Cara...

Jan 09, 2014, 10:03 ET

Enteris BioPharma to Present at Biotech Showcase™ 2014

 Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced that Timothy J. Saxon, Vice President of...

Dec 03, 2013, 08:33 ET

Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs

Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced the appointment of Steven J. Brickner, Ph.D.,...

Sep 30, 2013, 10:40 ET

Enteris BioPharma and Nordic BioScience's KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris' Proprietary Oral Drug Delivery and Manufacturing Platform

 Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, and KeyBioScience, a wholly-owned subsidiary of Nordic...

Aug 20, 2013, 08:33 ET

Enteris BioPharma Appoints Timothy J. Saxon, Vice President of Business Development, to Expand "Peptelligence™ Partnering" Program

Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced the appointment of Timothy J. Saxon as Vice...

Aug 05, 2013, 08:01 ET

Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics

 Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced the official launch of its business,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer